Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: A study from North India

Archives of Toxicology

Volumn 82, Issue 9, 2008, Pages 633-639

  Srivastava, Daya Shankar ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Bladder cancer (CaB); Cytochrome P450 1A1; Genetic polymorphisms; Microsomal epoxide hydrolase; Polymerase chain reaction restriction fragment length polymorphism

Indexed keywords

CYTOCHROME P450 1A1; EPOXIDE HYDROLASE; MICROSOME ENZYME;

ADULT; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DETOXIFICATION; DNA EXTRACTION; ENVIRONMENTAL FACTOR; ETHNICITY; EXON; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIA; INDIAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

CYTOCHROME P-450 CYP1A1; DNA; EPOXIDE HYDROLASES; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; MALE; MICROSOMES; MIDDLE AGED; PENETRANCE; POLYMORPHISM, GENETIC; TOBACCO USE DISORDER; URINARY BLADDER NEOPLASMS; VARIATION (GENETICS);

NICOTIANA TABACUM;

EID: 50649096119     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-007-0276-4     Document Type: Article

References (31)

1. AE Bale DW Nebert OW McBride 1987 Subchromosomal localization of the dioxin-inducible P1450 locus (CYP1) and description of two RFLPs detected within a 3' P1450 cDNA probe Cytogenet Cell Genet 46 574 575
2. J Brockmoller I Cascorbi R Kerb I Roots 1996 Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk Cancer Res 56 3915 3925
3. AG Casson Z Zheng GA Porter DL Guernsey 2006 Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma Cancer Detect Prev 30 5 423 431
4. F Crofts E Taioli J Trachman GN Cosma D Currie P Toniolo SJ Garte 1994 Functional significance of different human CYP1A1 genotypes Carcinogenesis 15 2961 2963
5. A Dorrenhaus T Muller PH Roos 2007 Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers Arch Toxicol 81 1 19 25
6. A Gsur T Zidek K Schnattinger E Feik G Haidinger P Hollaus A Mohn-Staudner C Armbruster S Madersbacher G Schatzl K Trieb C Vutuc M Micksche 2003 Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk Br J Cancer 89 4 702 706
7. C Hassett L Aicher JS Sidhu CJ Omiecinski 1994 Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants Hum Mol Genet 3 421 428
8. M Jacquet V Lambert E Baudoux M Muller P Kremers J Gielen 1996 Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence Eur J Cancer 32 1701 1706
9. LE Johns RS Houlston 2000 Glutathione S-transferase mu (GSTM1) status and bladder cancer risk: a meta analysis Mutagenesis 15 399 404
10. N Jourenkova-Mironova K Mitrunen C Bouchardy P Dayer S Benhamou A Hirvonen 2000 High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers Cancer Res 60 3 534 536
11. I Kiss Z Orsós K Gombos B Bogner A Csejtei A Tibold Z Varga E Pázsit I Magda A Zölyomi I Ember 2007 Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary Anticancer Res 27 4C 2931 2937
12. M Kogevinas A 't Mannetje S Cordier U Ranft CA Gonzalez P Vineis J Chang-Claude E Lynge J Wahrendorf A Tzonou KH Jockel C Serra S Porru M Hours E Greiser P Boffetta 2003 Occupation and bladder cancer among men in Western Europe Cancer Causes Control 14 907 914
13. JM Lancaster HA Browniee DA Bell A Futreal JR Marks A Berchuck RW Wiseman JA Taylor 1996 Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer Mol Carcinog 17 160 162
14. YC Lin DC Wu JM Lee HK Hsu EL Kao CH Yang MT Wu 2006 The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking Cancer Lett 237 2 281 288
15. KA McGlynn EA Rosvold ED Lustbader Y Hu ML Clapper T Zhou CP Wild XL Xia 1995 Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1 Proc Natl Acad Sci USA 92 2384 2387
16. RD Mittal DS Srivastava 2007 Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms, gene-environmental interaction and risk of prostate cancer DNA Cell Biol 26 11 791 798
17. T Murai Y Mori K Tatematsu A Koide A Hagiwara S Makino S Mori H Wanibuchi S Fukushima 2005 Differences in susceptibility to N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis Cancer Sci 96 10 637 644
18. GI Murray VE Taylor JA McKay RJ Weaver SW Ewen WT Melvin MD Burke 1995 Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder Int J Exp Pathol 76 271 276
19. H Norppa 2004 Cytogenetic biomarkers and genetic polymorphisms Toxicol Lett 149 309 334
20. R Pastorelli M Guanci A Cerri E Negri C La Vecchia F Fumagalli M Mezzetti R Cappelli T Panigalli R Fanelli L Airoldi 1998 Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide Cancer Epidemiol Biomarkers Prev 7 703 709
21. SA Salama CH Sierra-Torres HY Oh FA Hamada WW Au 2001 Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene Environ Mol Mutagen 37 17 26
22. Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning-A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
23. Silverman DT, Rothman N, Devesa SS (1999) Epidemiology of bladder cancer. In: Syrigos KN, Skinner DG (eds) Bladder cancer. Biology, diagnosis, management. Oxford University Press Inc., New York, pp 11-55
24. CA Smith DJ Harrison 1997 Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema Lancet 350 630 633
25. DS Srivastava A Kumar B Mittal RD Mittal 2004 Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India Arch Toxicol 78 430 434
26. DS Srivastava DK Mishra A Mandhani A Kumar B Mittal RD Mittal 2005 Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer Eur Urol 48 2 339 344
27. CM Ulrich J Bigler JA Whitton R Bostick L Fosdick JD Potter 2001 Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake Cancer Epidemiol Biomarkers Prev 10 875 882
28. P Vineis M Alavanja S Garte 2004 Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation Int J Cancer 108 2 7
29. Weber WW (1997) Human drug metabolizing enzyme variants. In: Roberts Frazare JA, Carter CO (eds) Pharmacogenetics. Oxford University Press, London, pp 204-210
30. A Wolf A Kutz S Plottner C Behm HM Bolt W Follmann J Kuhlmann 2005 The effect of benzo(a)pyrene on porcine urinary bladder epithelial cells analyzed for the expression of selected genes and cellular toxicological endpoints Toxicology 207 255 269
31. Young J (ed) (1997) Cancer incidence in five continents, vol VII. International Agency for Research on Cancer (IARC), Lyon, Scientific Publication 143